Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy.

acute cholecystitis common bile duct stone guidewire malignant biliary obstruction

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
16 Dec 2020
Historique:
received: 29 10 2020
revised: 04 12 2020
accepted: 11 12 2020
entrez: 19 12 2020
pubmed: 20 12 2020
medline: 20 12 2020
Statut: epublish

Résumé

The guidewire (GW) plays an important role in pancreatobiliary endoscopy. GW quality is a critical factor in the effectiveness and efficiency of pancreatobiliary endoscopy. In this study, we evaluate a new 0.025 inch multipurpose endoscopic GW: the M-Through. Our study was a multicenter retrospective analysis. We enrolled patients who underwent endoscopic procedures using the M-Through between May 2018 and April 2020. Patients receiving the following endoscopic treatments were enrolled: common bile duct (CBD) stone extraction, endoscopic drainage for distal and hilar malignant biliary obstruction (MBO), and endoscopic drainage for acute cholecystitis. For each procedure, we examined the rate of success without GW exchange. A total of 170 patients (80 with CBD stones, 60 with MBO, and 30 with cholecystitis) were enrolled. The rate of completion without GW exchange was 100% for CBD stone extraction, 83.3% for endoscopic drainage for MBO, and 43.3% for endoscopic drainage for cholecystitis. In unsuccessful cholecystitis cases with the original GW manipulator, 1 of 8 cases succeeded in the manipulator exchange. Including 6 cases who changed GW after the manipulator exchange, 11 of 16 cases succeeded in changing GW. There was significant difference in the success rate between the manipulator exchange and GW exchange ( The 0.025 inch M-Through can be used for endoscopic retrograde cholangiopancreatography-related procedures efficiently and safely. Our study found high rates of success without GW exchange in all procedures except for endoscopic drainage for cholecystitis. This GW is considered (1) excellent for supportability of device insertion to remove CBD stones; (2) good for seeking the biliary malignant stricture but sometimes need the help of a hydrophilic GW; (3) suboptimal for gallbladder drainage that require a high level of seeking ability.

Sections du résumé

BACKGROUND BACKGROUND
The guidewire (GW) plays an important role in pancreatobiliary endoscopy. GW quality is a critical factor in the effectiveness and efficiency of pancreatobiliary endoscopy. In this study, we evaluate a new 0.025 inch multipurpose endoscopic GW: the M-Through.
METHODS METHODS
Our study was a multicenter retrospective analysis. We enrolled patients who underwent endoscopic procedures using the M-Through between May 2018 and April 2020. Patients receiving the following endoscopic treatments were enrolled: common bile duct (CBD) stone extraction, endoscopic drainage for distal and hilar malignant biliary obstruction (MBO), and endoscopic drainage for acute cholecystitis. For each procedure, we examined the rate of success without GW exchange.
RESULTS RESULTS
A total of 170 patients (80 with CBD stones, 60 with MBO, and 30 with cholecystitis) were enrolled. The rate of completion without GW exchange was 100% for CBD stone extraction, 83.3% for endoscopic drainage for MBO, and 43.3% for endoscopic drainage for cholecystitis. In unsuccessful cholecystitis cases with the original GW manipulator, 1 of 8 cases succeeded in the manipulator exchange. Including 6 cases who changed GW after the manipulator exchange, 11 of 16 cases succeeded in changing GW. There was significant difference in the success rate between the manipulator exchange and GW exchange (
CONCLUSION CONCLUSIONS
The 0.025 inch M-Through can be used for endoscopic retrograde cholangiopancreatography-related procedures efficiently and safely. Our study found high rates of success without GW exchange in all procedures except for endoscopic drainage for cholecystitis. This GW is considered (1) excellent for supportability of device insertion to remove CBD stones; (2) good for seeking the biliary malignant stricture but sometimes need the help of a hydrophilic GW; (3) suboptimal for gallbladder drainage that require a high level of seeking ability.

Identifiants

pubmed: 33339093
pii: jcm9124059
doi: 10.3390/jcm9124059
pmc: PMC7765498
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Dig Dis Sci. 2020 Jun 25;:
pubmed: 32588249
Gastrointest Endosc. 2009 Sep;70(3):588-90
pubmed: 19555937
World J Gastroenterol. 2015 Aug 14;21(30):9182-8
pubmed: 26290646
Gastrointest Endosc. 2012 Feb;75(2):362-72, 372.e1
pubmed: 22248605
Dig Endosc. 2018 Mar;30(2):245-251
pubmed: 28722284
Endoscopy. 2011;43 Suppl 2 UCTN:E98-9
pubmed: 21425030
World J Gastrointest Endosc. 2017 Feb 16;9(2):77-84
pubmed: 28250900
Gastrointest Endosc. 2009 Dec;70(6):1211-9
pubmed: 19962504
Clin Endosc. 2020 Nov;53(6):678-685
pubmed: 31914724
Endoscopy. 2019 Nov;51(11):E349-E351
pubmed: 31174219
Dig Endosc. 2014 May;26(3):442-9
pubmed: 23937334
World J Gastroenterol. 2011 Dec 14;17(46):5131-2
pubmed: 22171149
Gastrointest Endosc. 2010 May;71(6):1038-45
pubmed: 20438890
J Hepatobiliary Pancreat Sci. 2020 Jul;27(7):429-436
pubmed: 32352636
Clin Endosc. 2020 Jan;53(1):65-72
pubmed: 31382731
Dig Liver Dis. 2011 Oct;43(10):788-91
pubmed: 21676663
Can J Gastroenterol Hepatol. 2016;2016:5825230
pubmed: 27446851

Auteurs

Shigeto Ishii (S)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Toshio Fujisawa (T)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Hiroyuki Isayama (H)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Shingo Asahara (S)

Department of Gastroenterology, Chiba Tokushukai Hospital, Chiba 274-8505, Japan.

Shingo Ogiwara (S)

Department of Gastroenterology, Juntendo University School of Medicine Urayasu Hospital, Chiba 279-0021, Japan.

Hironao Okubo (H)

Department of Gastroenterology, Juntendo University School of Medicine Nerima Hospital, Tokyo 117-8521, Japan.

Hisafumi Yamagata (H)

Department of Gastroenterology, Tobu Chiiki Hospital, Tokyo 125-8512, Japan.

Mako Ushio (M)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Sho Takahashi (S)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Hiroki Okawa (H)

Department of Gastroenterology, Juntendo University School of Medicine Urayasu Hospital, Chiba 279-0021, Japan.

Wataru Yamagata (W)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Yoshihiro Okawa (Y)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Akinori Suzuki (A)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Yusuke Takasaki (Y)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Kazushige Ochiai (K)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Ko Tomishima (K)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Hiroaki Saito (H)

Department of Gastroenterology, Juntendo University School of Medicine Nerima Hospital, Tokyo 117-8521, Japan.

Shuichiro Shiina (S)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo 113-8421, Japan.

Takaaki Ikari (T)

Department of Gastroenterology, Tobu Chiiki Hospital, Tokyo 125-8512, Japan.

Classifications MeSH